About
Taudia develops ultrasensitive protein biomarker quantification technology for neurodegenerative diseases, enabling detection using standard qPCR instruments through their SPLASH™ platform and associated assay kits.
Explore Taudia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.